These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 7424690)

  • 1. Hyperuricosuric calcium oxalate nephrolithiasis.
    Coe FL
    Adv Exp Med Biol; 1980; 128():439-50. PubMed ID: 7424690
    [No Abstract]   [Full Text] [Related]  

  • 2. Examination of the urinary potential of hyperuricosuric patients to retard calcium oxalate precipitation.
    Goldwasser B; Sarig S; Azoury R; Orda S; Boichis H; Wax Y; Many M
    Eur Urol; 1985; 11(1):40-3. PubMed ID: 3987747
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hyperuricosuric calcium nephrolithiasis.
    Sorensen CM; Chandhoke PS
    Endocrinol Metab Clin North Am; 2002 Dec; 31(4):915-25. PubMed ID: 12474638
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of oral purine load and allopurinol on the crystallization of calcium salts in urine of patients with hyperuricosuric calcium urolithiasis.
    Pak CY; Barilla DE; Holt K; Brinkley L; Tolentino R; Zerwekh JE
    Am J Med; 1978 Oct; 65(4):593-9. PubMed ID: 707519
    [No Abstract]   [Full Text] [Related]  

  • 5. Hyperuricosuria and calcium nephrolithiasis.
    Coe FL; Parks JH
    Urol Clin North Am; 1981 Jun; 8(2):227-44. PubMed ID: 7268958
    [No Abstract]   [Full Text] [Related]  

  • 6. Change in inhibitory potential in urine of hyperuricosuric calcium oxalate stone formers effected by allopurinol and orthophosphates.
    Goldwasser B; Sarig S; Azoury R; Wax Y; Hirsch D; Perlberg S; Many M
    J Urol; 1984 Nov; 132(5):1008-11. PubMed ID: 6492268
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Calcium restriction, thiazide, citrate, and allopurinol in calcium oxalate nephrolithiasis.
    Coe FL
    Acta Urol Belg; 1994 Jun; 62(2):25-9. PubMed ID: 8037000
    [No Abstract]   [Full Text] [Related]  

  • 8. Successful treatment of hyperuricosuric calcium oxalate nephrolithiasis with potassium citrate.
    Pak CY; Peterson R
    Arch Intern Med; 1986 May; 146(5):863-7. PubMed ID: 3963975
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical characteristics and pathogenetic mechanisms in hyperuricosuric calcium oxalate renal stone disease.
    Favus MJ; Coe FL
    Scand J Urol Nephrol Suppl; 1980; 53():171-7. PubMed ID: 6937993
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The effects of allopurinol treatment on stone formation on hyperuricosuric calcium oxalate stone-formers.
    Favus MJ; Coe FL
    Scand J Urol Nephrol Suppl; 1980; 53():265-71. PubMed ID: 6938003
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hyperuricosuric calcium oxalate nephrolithiasis.
    Coe FL
    Kidney Int; 1978 May; 13(5):418-26. PubMed ID: 661071
    [No Abstract]   [Full Text] [Related]  

  • 12. [Physiopathological diagnosis of changes in uric acid metabolism: hyperuricuria and nephrolithiasis].
    García Puig J; Mateos Antón F; Ramos T
    Med Clin (Barc); 1987 Sep; 89(8):339-47. PubMed ID: 3320609
    [No Abstract]   [Full Text] [Related]  

  • 13. Impact of allopurinol treatment on the prevention of hyperuricosuric calcium oxalate lithiasis.
    Hofbauer J; Zechner O
    Eur Urol; 1988; 15(3-4):227-9. PubMed ID: 3215256
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Interaction of hyperuricuria and hyperoxaluria on renal calcium oxalate stone formation.
    Hering F; Bigalke KH; Lutzeyer W
    Adv Exp Med Biol; 1980; 122A():99-107. PubMed ID: 7424665
    [No Abstract]   [Full Text] [Related]  

  • 15. The hyperuricosuric calcium oxalate stone former.
    Sarig S
    Miner Electrolyte Metab; 1987; 13(4):251-6. PubMed ID: 3306317
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A review of possible roles of urates in calcium oxalate urolithiasis.
    Brockis JG; Bowyer RC; McCulloch RK
    Scand J Urol Nephrol Suppl; 1980; 53():179-85. PubMed ID: 6937994
    [No Abstract]   [Full Text] [Related]  

  • 17. Randomized trial of allopurinol in the prevention of calcium oxalate calculi.
    Ettinger B; Tang A; Citron JT; Livermore B; Williams T
    N Engl J Med; 1986 Nov; 315(22):1386-9. PubMed ID: 3534570
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Uric acid-related nephrolithiasis.
    Low RK; Stoller ML
    Urol Clin North Am; 1997 Feb; 24(1):135-48. PubMed ID: 9048857
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of hyperprotidic diet associated or not with hypercalcic diet on calcium oxalate stone formation in rat.
    Sakly R; Bardaoui M; Neffati F; Moussa A; Zakhama A; Najjar MF; Hammami M
    Ann Nutr Metab; 2005; 49(2):132-8. PubMed ID: 15860912
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Metabolic basis of renal-stone disease.
    Broadus AE; Thier SO
    N Engl J Med; 1979 Apr; 300(15):839-45. PubMed ID: 34098
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.